The commercial success of the injectable peptide-based weight-loss drugs marketed by Novo Nordisk and Eli Lilly and Company made one thing clear for Xiayang Qiu, a structural chemist and biotechnology ...

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

Weight loss supplements are a big industry, but do they actually work? A dietitian explores the evidence, efficacy, and ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

showed participants experienced sustained weight loss. People with class 1 obesity lost on average 6.3% of their total body weight. Sirona is a dual-polymer hydrogel pill that expands in the stomach, ...

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and ... The average LLY price target of $1,015.85 implies 16.71% upside from current levels. Read more analyst ratings on ...

Despite what the wellness industry might have you believe, there are no quick fixes, miracle cures or magic pills when it comes to weight loss. Losing weight requires dedication to a plan that ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide. “We feel that a product like an oral, orforglipron, could serve a significant ...